Shattuck Labs, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| STTK | CLYM | ACRS | GLUE | AGEN | CHRS | |
|---|---|---|---|---|---|---|
| Market cap | 516.87M | 535.88M | 570.34M | 923.09M | 314.78M | 131.36M |
| P/E (TTM) | — | — | — | — | 2.8 | — |
| Forward P/E | -10.0 | -9.3 | -5.1 | -5.9 | -63.4 | -1.3 |
| Price/book | 2.5 | 2.2 | 4.1 | 1.9 | -1.5 | 2.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +168.14% | +407.81% | +65.49% | −15.43% | +80.76% | −48.50% |
| Today | −5.85% | −4.31% | −1.60% | +3.94% | +4.50% | +5.54% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All STTK news ›Critical Contrast: Inovio Pharmaceuticals (NASDAQ:INO) & Shattuck Labs (NASDAQ:STTK)
Posted by Tristan Rich on Nov 1st, 2026 Shattuck Labs (NASDAQ:STTK – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast…
Comparing Celldex Therapeutics (NASDAQ:CLDX) & Shattuck Labs (NASDAQ:STTK)
Posted by Michael Walen on Oct 26th, 2026 Celldex Therapeutics (NASDAQ:CLDX – Get Free Report) and Shattuck Labs (NASDAQ:STTK – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two…
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
Presenter: Mahmud Hussain, Ph.D., Director, R&D of Shattuck Labs Date/Time: October 19, 2026; 1:00-2:00 p.m. CEST Title: Soluble TL1A/Anti-TL1A Immune Complexes Induce De Novo Production of TL1A and Induce Anti-Drug Antibodies That…
Shattuck Labs to present new antibody research at UEG Week 2026 in Barcelona
Shattuck Labs, a clinical-stage biotech company, announced two poster presentations at the United European Gastroenterology (UEG) Week 2026 in Barcelona. The presentations will showcase their development of SL-846, a novel bispecific…
Shattuck Labs (NASDAQ:STTK) Stock Falls 5.3% – Should You Sell?
Posted by Defense World Staff on Oct 7th, 2026 Shattuck Labs, Inc. (NASDAQ:STTK – Get Free Report) shares fell 5.3% during mid-day trading on Monday. The company traded as low as $6.33 and last traded at $6.3760. 599,094 shares traded…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com3
- defenseworld.net1
- pluang.com1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.